| Abstrakt: |
Background: Quality of life obtained from patients' data is becoming a significant part of treatment efficiency evaluation. Up until nw, there was not a study dedicated to QoL in patients with hypothereosis and hyperthereosis in Slovakia. Methods: To find out the Quality of Life (QoL) in this study, an original QoL questionnaire developed by Faculty of Health, Alexander Dubcek university in Trencin (FoH TnUAD) was used. The questionnaire is predominantly generic, and oriented towards work ability (WA) as wells as QoL. The results were processed using basic statistical methods included in Excel 2013 software, while to determine statistically significant differences of the parametres compared Dunn's, Friedman's and Mann-Whitney' s tests were used. Results: When evaluating the whole set, the current quality of life was at 7.8, at the time of diagnosing the disease it was 5.8, at the time of disease - 8.2, and finally in the time of full health, the quality of life reached 9.0 (1- worst, 10- best). In the group of patients with hyperthyroidism compared to the group of patients with hypothyroidism, results were: 6.4 vs. 7.3; 4.6 vs. 6.0; 7.6 vs. 8.3; 8.0 vs. 9.2. The average treatment time was 11.3 years. The mean duration of the symptoms before the diagnosis was 0.9 years. Patients visited an endocrionologist due to the disease 2.7 times a year and their general practitioner for an average of 3.4 times a year. Patients also evaluated their own personality, which can determine the perception of overall quality of life, ranging from 1 (pessimistic) to 5 (optimistic). The assessment of the expectations for the future was as follows: (1- worst, 5- best): health expectations 3.6; economical - 3,4; working - 3,6. Family expectations reached the highest rating - 4.2. Patients evaluated their disease awareness on a 5-point scale at 4.3, provided medical care 4.7, and nursing care 4.7 (1- worst, 5- best). Conclusions: Quality of life varies significantly at the time of diagnosis and in treatment, both in hypothyroidism and hyperthyroidism. Quality of life is significantly worse at the time of diagnosis in hyperthyroidism. Drugs (Thyrozol, Propycil) have no significant effect on the quality of life in the treatment of hyperthyroidism. Drugs (Euthyrox, L-Thyroxine BCH) have no significant effect on the quality of life in the treatment of hypothyroidism. The quality of life in patients with total strumectomy or unilateral lobectomy does not differ from patients with hypothyroidism and hyperthyroidism. [ABSTRACT FROM AUTHOR] |
